Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

  1. Kaplan, S.A.
  2. Herschorn, S.
  3. McVary, K.T.
  4. Staskin, D.
  5. Chapple, C.
  6. Foley, S.
  7. Cambronero Santos, J.
  8. Kristy, R.M.
  9. Choudhury, N.
  10. Hairston, J.
  11. Schermer, C.R.
Zeitschrift:
The Journal of urology

ISSN: 1527-3792

Datum der Publikation: 2020

Ausgabe: 203

Nummer: 6

Seiten: 1163-1171

Art: Artikel

DOI: 10.1097/JU.0000000000000738 GOOGLE SCHOLAR